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Abstract 
 
         Oesophageal tumours are either benign or malignant. Benign 
tumours are mostly mesenchymal in origin. With rare exceptions, 
malignant oesophageal tumours arise from the epithelial layer. 
          This is a retrospective study conducted in Sudanese patients at Ibn 
Sina hospital and NHL. The aim of the study is to determine 
histopathological pattern, age and sex distribution of oesophageal 
tumours. 
          The study comprised 102 patients of which 44 were males and 58 
were females with a male to female ratio of 1:1.3. The age of all patients 
ranged between 29 – 90 with a mean of 65 years. 
         In this study no benign tumour was identified and all the cases were 
malignant tumours the histology of which was SCC and adenocarcinoma. 
The SCC being predominant comprising 89.1 %, with a male to female 
ratio of 1:1.6. There is striking male predominance in adenocarcinoma 
(10:1) 
         By revising the slides: 85 were SCC (83 %) , 4 basoloid squamous 
cell carcinoma (4%), 2 spindle cell carcinoma (2 %), 9 adenocarcinoma 
(9%), 1 case papillary carcinoma (1 % ) , one case signet ring cell 
carcinoma and 1 anaplastic carcinoma (1%).  
         Invasive SCC represented the majority of cases (88%) while only 
12% were intraepithelial. 
          In conclusion benign tumours and other tumours like carcinoid, 
lymphomas etc are rare. SCC is the most common oesophageal cancer in 
Sudanese patients as it is the case worldwide. Intraepithelial neoplasia is 
under diagnosed and this raises the importance of screening programs. 
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  ﺺ ﺍﻷﻃﺮﻭﺣﺔﻣﻠﺨ
ﺗﻨﻤﻮ ﻣﻌﻈﻢ ﺍﻷﻭﺭﺍﻡ ﺍﻟﺤﻤﻴﺪﺓ ﻣﻦ ﺍﻟﻨـﺴﻴﺞ .     ﺗﻨﻘﺴﻢ ﺃﻭﺭﺍﻡ ﺍﻟﻤﺮﺉ ﺍﻟﻲ ﺃﻭﺭﺍﻡ ﺣﻤﻴﺪﺓ ﻭ ﺃﻭﺭﺍﻡ ﺧﺒﻴﺜﺔ 
ﻫﺬﻩ ﺍﻟﺪﺭﺍﺳﺔ  . ﺑﻴﻨﻤﺎ ﺗﻨﻤﻮ ﻣﻌﻈﻢ ﺍﻷﻭﺭﺍﻡ ﺍﻟﺨﺒﻴﺜﺔ ﻣﻦ ﺍﻟﺨﻼﻳﺎ ﺍﻟﻤﺒﻄﻨﺔ ﻟﻠﻐﺸﺎﺀ ﺍﻟﺪﺍﺧﻠﻰ ﻟﻠﻤﺮﺉ . ﺍﻷﻭﺳﻂ
ﻰ ﺍﺑﻦ ﺳﻴﻨﺎﺀ ﻭﺍﻟﻤﻌﻤـﻞ ﺃﺟﺮﻳﺖ ﻓﻰ ﻣﺴﺘﺸﻔ . ﺍﻟﻰ ﺍﻟﻮﺭﺍﺀ ﻋﻦ ﺃﻭﺭﺍﻡ ﺍﻟﻤﺮﺉ ﻓﻰ ﺍﻟﻤﺮﺿﻰ ﺍﻟﺴﻮﺩﺍﻧﻴﻴﻦ 
ﺗﻬﺪﻑ ﺍﻟﺪﺭﺍﺳﺔ ﺍﻟﻰ ﺑﺤﺚ ﺍﻟﺘﻐﻴﺮﺍﺕ ﺍﻟﻤﺮﺿﻴﺔ ﻓﻲ ﺍﻷﻧـﺴﺠﺔ ﻭﻣﻌﺮﻓـﺔ . ﺍﻟﻘﻮﻣﻰ ﺍﻟﺼﺤﻰ ﺑﺎﻟﺨﺮﻃﻮﻡ  
  .ﺗﻮﺯﻳﻊ ﺍﻟﻤﺮﺽ ﻓﻰ ﺍﻷﻋﻤﺎﺭ ﺍﻟﻤﺨﺘﻠﻔﺔ ﻭ ﻋﻼﻗﺔ ﻧﻮﻉ ﺍﻟﻤﺮﺽ ﻣﻊ ﺍﻟﺠﻨﺲ
ﻧـﺴﺒﺔ ﺍﻟﻤﺮﺿـﻰ ﻣـﻦ .  ﻣﻦ ﺍﻟﻨﺴﺎﺀ 85 ﻣﻦ ﺍﻟﺮﺟﺎﻝ ﻭ 44 ﻣﺮﻳﺾ ﻣﻨﻬﻢ 201      ﺗﻀﻤﻨﺖ ﺍﻟﺪﺭﺍﺳﺔ 
  . ﺳﻨﺔ56 ﺳﻨﺔ ﻭ ﻣﺘﻮﺳﻂ ﺍﻷﻋﻤﺎﺭ 09-92 ﻭﺗﺮﺍﻭﺣﺖ ﺍﻷﻋﻤﺎﺭ ﺑﻴﻦ 1:3.1 ﺍﻟﺮﺟﺎﻝ ﺍﻟﻰ ﺍﻟﻨﺴﺎﺀ
   ﻟﻢ ﺗﺼﺎﺩﻑ ﻫﺬﻩ ﺍﻟﺪﺭﺍﺳﺔ ﺍﻯ ﺣﺎﻟﺔ ﻭﺭﻡ ﺣﻤﻴﺪ، ﻭﻛﺎﻧﺖ ﺍﻟﺤﺎﻻﺕ ﺃﻭﺭﺍﻡ ﺧﺒﻴﺜﺔ ﺍﻣﺎ ﻧﺎﺷﺌﺔ ﻣﻦ ﺍﻟﺨﻼﻳﺎ 
ﺃﻭ . ﻭﺗﻮﺯﻳﻊ ﺍﻟﻤﺮﺽ ﺷﺒﻪ ﻣﺘﻤﺎﺛﻞ ﻓﻰ ﺍﻟﺠﻨـﺴﻴﻦ  % 1.98ﺍﻟﻤﺒﻄﻨﺔ ﻟﻠﻐﺸﺎﺀ ﺍﻟﺪﺍﺧﻠﻰ ﻟﻠﻤﺮﺉ ﻭﻫﻰ ﺗﻤﺜﻞ 
   (. 01:1) ﺒﺔ ﺍﻟﺮﺟﺎﻝ ﺗﻔﻮﻕ ﻧﺴﺒﺔ ﺍﻟﻨﺴﺎﺀ ﻓﻰ ﺍﻻﺻﺎﺑﺔ ﺳﺮﻃﺎﻥ ﻏﺪﺩﻯ ﻭ ﻫﻨﺎ ﻧﺴ
 ﺣﺎﻟﺔ ﺳﺮﻃﺎﻥ ﻧﺎﺷﺊ ﻣﻦ ﺍﻟﺨﻼﻳﺎ ﺍﻟﻤﺒﻄﻨﺔ ﻟﻠﻐﺸﺎﺀ ﺍﻟﺪﺍﺧﻠﻰ ﻟﻠﻤﺮﺉ 58    ﺑﺎﻟﺮﺟﻮﻉ ﺍﻟﻰ ﺍﻟﺸﺮﺍﺋﺢ ﻭﺟﺪﺕ 
 ﺣـﺎﻻﺕ ﺳـﺮﻃﺎﻥ 9، %(2)، ﺣﺎﻟﺘﺎﻥ ﺳﺮﻃﺎﻥ ﻣﻐﺰﻟـﻰ %( 4) ﺣﺎﻻﺕ ﺳﺮﻃﺎﻥ ﻗﺎﻋﺪﻯ 4، %( 38)
، ﻭ ﺣﺎﻟـﺔ %(1)ﻭﺍﺣﺪﺓ ﺳـﺮﻃﺎﻥ ﺣﻠﻴﻤـﻰ ، ﺣﺎﻟﺔ %(1)، ﺣﺎﻟﺔ ﻭﺍﺣﺪﺓ ﺳﺮﻃﺎﻥ ﺧﺎﺗﻤﻰ %(9)ﻏﺪﺩﻯ 
ﻣﻦ ﺣﺎﻻﺕ ﺍﻟﺴﺮﻃﺎﻥ ﺍﻟﻨﺎﺷﺊ ﻣﻦ ﺍﻟﺨﻼﻳﺎ ﺍﻟﻤﺒﻄﻨﺔ % 88%(. 1)ﻭﺍﺣﺪﺓ ﺳﺮﻃﺎﻥ ﻣﺘﺤﻮﻝ ﺃﻭ ﺍﺭﺗﺪﺍﺩﻯ 
  .ﻏﻴﺮ ﻣﺘﻐﻠﻐﻞ% 21ﻟﻠﻐﺸﺎﺀ ﺍﻟﺪﺍﺧﻠﻰ ﻟﻠﻤﺮﺉ ﻛﺎﻥ ﺳﺮﻃﺎﻥ ﻣﺘﻐﻠﻐﻞ ﻭ 
.     ﺧﻠﺼﺖ ﺍﻟﺪﺭﺍﺳﺔ ﺍﻟﻰ ﺃﻥ ﺍﻷﻭﺭﺍﻡ ﺍﻟﺤﻤﺒﺪﺓ ﻭ ﺑﻌﺾ ﺍﻷﻭﺭﺍﻡ ﺍﻟﺨﺒﻴﺜﺔ ﻓﻰ ﺍﻟﻤﺮﺉ ﻧﺎﺩﺭﺓ ﺍﻟﺤـﺪﻭﺙ 
ﻥ ﺍﻟﻨﻮﻉ ﺍﻷﻛﺜﺮ ﺍﻧﺘﺸﺎﺭﺍ ﺑﻴﻦ ﺍﻟﻤﺮﺿﻰ ﺍﻟﺴﻮﺩﺍﻧﻴﻴﻦ ﻫﻮ ﺍﻟﺴﺮﻃﺎﻥ ﺍﻟﻨﺎﺷﺊ ﻣـﻦ ﺍﻟﺨﻼﻳـﺎ ﺍﻟﻤﺒﻄﻨـﺔ ﻭﺃ
ﻭ ﺃﻥ ﻣﻌﻈـﻢ ﺍﻻﻟﺤـﺎﻻﺕ ﺍﻟﺘـﻰ ﺗـﻢ . ﻟﻠﻐﺸﺎﺀ ﺍﻟﺪﺍﺧﻠﻰ ﻟﻠﻤﺮﺉ ﻛﻤﺎ ﻫﻮ ﺍﻟﺤﺎﻝ ﻓﻰ ﻏﺎﻟﺐ ﺑﻠﺪﺍﻥ ﺍﻟﻌـﺎﻟﻢ 
XI 
ﻭ ﺃﺷﺎﺭﺕ ﺍﻟﺪﺭﺍﺳﺔ ﺍﻟﻰ ﺃﻫﻤﻴﺔ ﺍﻟﻔﺤﺺ ﺍﻟﻄﺒﻰ ﺍﻟﺪﻭﺭﻯ (. ﺳﺮﻃﺎﻥ ﻣﺘﻐﻠﻐﻞ ) ﺗﺸﺨﻴﺼﻬﺎ ﺣﺎﻻﺕ ﻣﺘﻘﺪﻣﺔ 
  .    ﻋﻤﺎﺭ ﺍﻟﺘﻰ ﻳﻜﺜﺮ ﻓﻴﻬﺎ ﺣﺪﻭﺙ ﺍﻟﻤﺮﺽﺧﺎﺻﺔ ﻟﻸ
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(1) Introduction:   
        Benign tumors of the oesophagus are over shadowed 
by cancer of the esophagus. However, they can be a cause of 
morbidity and can lead to dysphagia and thoracic pain.  The 
frequency of leiomyomas which are the most common benign 
tumors of the esophagus has been found to be almost 8% (1). 
Carcinomas of the esophagus raised a considerable medical and 
public health challenge in many parts of the world. Morphologically 
and etiologically two major types are distinguished, squamous cell 
carcinoma and adenocarcinoma (2). Worldwide, squamous cell 
carcinoma (SCC) constitutes 90% of esophageal cancers but in 
the United States there has been an exceptional increase in the 
incidence of adenocarcinomas associated with Barrett esophagus 
(3).  Analysis of incidence rates by subsite and subtype showed an 
increase in adenocarcinomas of the oesophagus and gastric 
cardia, largely restricted to males. In females, the rise in incidence 
of squamous cell carcinoma of the oesophagus appeared to be 
more marked than the rise in adenocarcinomas (4). Most cases of 
oesophageal carcinomas occur in adults older than the age of 50 
with a male to female ratio of 3:1.  There are striking and puzzling 
differences in the geographic incidence of esophageal carcinoma.  
In the United States, there are about 6 new cases per 100,000 
population per year, accounting for 1% to 2% of all cancer deaths.  
In regions of Asia extending from the Northern Provinces of China 
to the Caspian Littoral in Iran, the prevalence is well over 100 per 
100,000, and 20% of cancer deaths are caused by oesophageal 
cancer (mainly squamous cell type), with females being affected 
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more often than males.  These epidemiologic contrasts must 
contain causative clues that remain to be deciphered (3). The 
incidence in the Sudan is 1.4% of all malignant tumours. The 
disease affected both sexes equally; is most common at the age of 
50-69 and is commoner in patients from the North. (5). 
The risk factors for squamous cell carcinomas of the 
esophagus include esophageal disorders like longstanding 
esophagitis, achalasia, and Plummer Vinson syndrome.  Smoking 
and alcohol are two important and well known risk factors.  
However, different influences must underline the very high 
incidence of this tumor among Moslems of Iran, who neither drink 
nor smoke.  Dietary factors like deficiency of vitamins and trace 
metals, fungal contamination of food stuffs and high content of 
nitrites, nitrosamine are invoked.   Strong association with human 
papilloma virus is noted in high incidence areas (3). It is suggested 
that ethnicity may influence esophageal cancer histology or ethnic 
background may place an individual at increased risk for certain 
types of esophageal cancer (6).The role of genetic predisposition 
is extremely ill-defined but the rare genetic syndrome of tylosis 
(hyperkeratosis of palms and soles) carries an almost certain 
probability of the development of esophageal cancer.  Barret 
esophagus is the only recognized precursor of esophageal 
adenocarcinoma (3).          
Esophageal lesions evoke a similar and remarkably limited 
range of symptoms.  All produce dysphagia which is attributed 
either to deranged esophageal motor function or obstruction of the 
lumen ( 3). 
Exfoliative cytology in experienced hands is an extremely 
accurate technique for the evaluation of esophageal lesions 
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particularly those of the lower third.  For many years, it was clearly 
superior to radiography or endoscopy.  However, since the 
introduction of the flexible fiberoptic endoscope, the diagnostic 
accuracy of direct-vision biopsy has become as high as that of 
cytology (1).  
Only a small number of genotypes have been obtained on 
carcinomas of the esophagus, and most of these have been 
incomplete. Of the genes known to be altered in SCC of the 
esophagus, TP53 is most often found to be abnormal.  The 
contribution of molecular studies to the prognosis of SCC of the 
esophagus is not yet firmly established (7).  
Radiation therapy is the most common form of treatment for 
carcinomas of the upper two thirds of the esophagus and surgery 
(in the form of oesophagastrectomy) is usually performed for 
carcinoma of the lower third.  Some authors advocated a 
combination of chemotherapy and radiation therapy, with or 
without surgery.  In inoperable cases considerable palliation can 
still be achieved by well-planned irradiation (1).  
Despite progress in therapy, carcinomas of the esophagus 
remain a tumor with somber prognosis.  Patients often present with 
relatively advanced tumor because the tumor remains 
asymptomatic for a long interval.  Progression of squamous cell 
carcinomas of the esophagus has been recorded to take 3 to 4 
years (7). 
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Literature review 
 
 
    (1) Anatomy and physiology of the esophagus:- 
 The esophagus is a muscular tube, about 25 cm (10 in) long 
connecting the pharynx to the stomach.  It begins in the neck at 
the caudal border of the cricoid cartilage. It pierces the diaphragm 
at the level of the tenth thoracic vertebra, and ends at the cardiac 
orifice of the stomach at the level of the eleventh thoracic vertebra.   
 Thus the esophagus is divided into cervical part, thoracic 
part and abdominal part. Arteries supplying the esophagus are 
derived from the inferior thyroid branch of the thyrocervical trunk, 
form the descending thoracic aorta, from the bronchial arteries, 
from the  left gastric branch of the celiac artery, and from the left 
inferior phrenic branch of the abdominal aorta.  The veins drain 
into the inferior thyroid veins, the azygos, hemiazygos and 
accessory hemiazygos veins.  The abdominal part drains partly 
into the azygos vein and partly into the left gastric vein.  The latter 
vein being a tributary of the portal vein. The lymph vessels from 
the upper third of the esophagus drains into the cervical nodes, the 
middle third into the paraeosophageal and paratracheal 
mediastinal nodes, and the lower third into the nodes around the 
aorta and celiac axis.The nerve supply is derived from the vagus 
and cervical sympathetic trunks (8).  
                   Physiologically the oesophagus normally exhibits two 
types of peristaltic movements: primary peristalsis and secondary 
peristalsis.  Primary peristalsis is simply a continuation of 
swallowing.  This wave passes all the way from the pharynx to the 
stomach in about 8 to 10 seconds.  If the primary wave fails to 
move all the food that has entered the esophagus into the 
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stomach, secondary peristaltic waves result from distension of the 
esophagus by the retained food, and they continue until all the 
food has emptied into the stomach.  These secondary waves are 
initiated partly by intrinsic neural circuits in the esophageal 
myenteric nervous system and partly by reflexes that are 
transmitted through vagal afferent fibers from the esophagus to the 
medulla and then back again to the esophagus through vagal 
efferent fibers. To prevent reflux of stomach contents into the 
esophagus the esophageal circular muscle functions as a lower 
esophageal sphincter or gastroesophageal sphincter at the lower 
end of the esophagus.  Anatomically, this sphincter is no different 
from the remainder of the esophagus.  Physiologically, it normally 
remains tonically constricted (with an intra-luminal pressure at this 
point in the esophagus of about 30 mm Hg), in contrast to the mid 
portion of the oesophagus between the upper and lower 
sphincters, which normally remains relaxed. Another factor that 
prevents reflux is a valve-like mechanism of that short portion of 
the esophagus that lies immediately beneath the diaphragm before 
reaching the stomach (9). 
  
  (2) Histology of the esophagus:- 
 The histological structure of the esophagus follows the same 
general pattern as the rest of the alimentary tract:- 
1. The fibrous layer (serosa):-  
It consists of an external adventitia of irregular, dense 
connective tissues containing many elastin fibers.  Its fibers also 
penetrate and surround the fasciculi of muscle in the deeper 
layers. 
2. The muscularis externa:- 
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It is 0.5-2.0 mm in thickness and consists of outer longitudinal 
and inner circumferential layers of muscle fibres.  In the initial 
portion of the esophagus, both layers are striated muscle.  In its 
middle third, smooth muscle fibres begin to appear deep to the 
striated muscle, and in the lower third, both layers of the 
muscularis consist entirely of smooth muscle.   
3. The submucosa:- 
It is 400-600 µm in thickness and contains interlacing bundles of 
collagen fibres, abundant elastic fibres, and many small blood  
vessels.  The mucosa and sub mucosa, in the un-distended 
esophagus, form broad longitudinal folds that give the lumen a 
highly irregular outline.   
4. The mucosa:- 
The esophageal mucosa is 300-500 µm thick and has an 
epithelium that is a continuation of the stratified squamous 
epithelium lining the oropharynx.  Stratum germinativum, stratum 
spinosum, and stratum corneum are identifiable, but the 
thickness and degree of keratinization of the stratum corneum 
vary greatly from species to species.  The superficial cells retain 
their nucleus and have a few keratohyalin granules in their 
cytoplasm but show little evidence of heavy keratinization.  Cells 
of the stratum spinosum have short microplicae that project into 
the intercellular spaces, and the processes of neighboring cells 
are attached by prominent desmosomes.  In addition to their 
organelles, these cells contain bundles of intermediate filaments 
and 120-150 nm vesicles that contain eccentrically placed dense 
material.  The base of the epithelium is quite irregular with 
closely spaced deep recesses in its under surface, occupied by 
papillae of the lamina propria.  The cells of the stratum 
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germinativum are cuboidal and have desmosomes on their 
interdiagitating lateral surfaces and hemidemosomes at their 
base. 
The intercellular spaces of the stratum corneum and outer 
portion of the stratum spinosum contain material that gives a 
strong staining reaction with Alcian blue at pH2.5 and is deeply 
stained with the periodic-acid-Schiff reaction for glyconjugates. 
5. Oesophageal glands:- 
Two kinds of esophageal glands are distinguished on the basis 
of their location.  (1)The superficial mucosal glands are limited to 
the lamina propria and are found in limited number in the upper 
oesophagus and near its junction with the stomach. They are 
tortuous tubular glands lines with cuboidal or columnar epithelial 
cells that resemble those of the cardiac glands of the stomach.  
Owing to this resemblance, these glands are sometimes called 
cardiac esophageal glands.  They are few in number and are 
interpreted by some as islands of ectopic gastric mucosa.  Their 
small ducts join a larger duct that usually opens at the tip of a 
small papilla. (2) The submucosal glands are more widespread 
and extend into the submucosa.They are tubuloacinar glands 
arranged in small lobules that are drained by a single duct.  The 
acini are made up of plump cells with their nucleus compressed 
to the base by droplets of mucus that occupy most of the cell 
volume.  A second cell type is cuboidal with a centrally placed 
nucleus, a basophilic cytoplasm, and somewhat smaller and 
denser secretory droplets or granules.  These cells are 
considered by some to be an earlier stage in the secretory cycle 
of the mucous cell, but others regard them as a separate serous 
cell type.   
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         Like the minor gland of the oral cavity, the oesophageal 
glands probably secrete, continuously maintaining a thin 
lubricating layer of mucus on the surface of the epithelium, but 
the rate of their secretion may be increased during the ingestion 
and swallowing of food (10). 
 
(3) Histopathology of oesophageal tumors: 
(A) Squamous epithelial tumors:  
  1- Squamous cell papilloma:- 
 Squamous cell papilloma is rare and usually causes no 
specific symptoms.  It is a benign tumor composed of hyperplastic 
squamous epithelium covering finger-like processes with cores 
derived from the lamina propria.   The polypoid lesions are smooth, 
sharply demarcated and usually 5 mm or less in maximum 
diameter.  Rarely, giant papillomas have been reported, with sizes 
up to 5 cm.  Most squamous cell papillomas represent single 
isolated lesions, typically located in the distal to middle third of the 
oesophagus, but multiple lesions occur. 
 Histologically cores of firbovascular tissue are covered by 
mature stratified squamous epithelium.  The aetiological role of 
human papillomavirus (HPV) infection has been investigated in 
several studies, but the results were inconclusive.  Malignant 
progression to SCC is extremely rare. 
2- Squamous cell carcinoma of the oesophagus 
  - Definition:- 
Squamous cell carcinoma (SCC) of the esophagus is a malignant 
epithelial tumor with squamous cell differentiation.  Microscopically 
it is characterized by keratinocyte-like-cells with intercellular 
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bridges and/or keratinization. Blacks have a fourfold to fivefold 
higher rate of squamous cell carcinoma than whites, but the rate of 
adenocarcinoma in blacks was 30% of the rate in whites. The 
incidence of squamous cell carcinoma in black men and women 
increased by approximately 30% between 1973 and 1982, and the 
rate of adenocarcinoma among white men increased 74%. (11)  
 -  Epidemiology :- 
Squamous cell carcinoma of the oesophagus shows great 
geographical diversity in incidence, mortality and sex ratio.  There 
are however, several well-defined high-risk areas e.g. Normandy 
and Calvados in North-West France and Northern Italy.  This type 
of cancer is much more frequent in Eastern countries and in many 
developing countries.  In both high-risk and low-risk regions, this 
cancer is exceedingly rare before the age of 30 and the median 
age is around 65 in both males and females. There was no 
significant difference between its involvement among males and 
females (12). In the past 20-30 years the incidence of squamous 
cell carcinoma (SC) of the esophagus in western countries has 
largely stayed constant, while that of adenocarcinoma (AC) of the 
oesophagus and the cardia has risen. (13). 
 - Etiology:- 
1- Tobacco and alcohol:-  In Western countries, nearly 90% of the 
risk of SCC can be attributed to tobacco and alcohol.  With regard 
to the consumption of tobacco, a moderate intake during a long 
period carries a higher risk than a high intake during a shorter 
period, whereas the reverse is true for alcohol. The oesophagus, 
stomach and pancreas are primary target organs for ethanol-
related diseases. In the oesophagus and stomach, ethanol induces 
motility disorders and mucosal lesions that are dose-dependent 
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and reversible under acute conditions. Chronic consumption of 
alcohol causes a significant increase in the risk for squamous 
carcinoma of the oesophagus. All of these effects are mainly 
caused by direct contact of alcohol or its metabolite acetaldehyde 
with the mucosa. Non-alcoholic components are responsible for 
many effects of alcoholic beverages, including the powerful 
stimulation of gastric acid secretion by beverages that are 
produced by fermentation. (14), Alterations of retinoic acid 
receptors protein may contribute in the development of SCC in 
esophagus and that in some patients life style (e.g. smoking and 
alcohol consumption) may be a critical component in the alteration 
of retinoic acid receptor levels in esophagus (15).  Because some 
of the causes of increased mean corpuscular volume (MCV) and 
oesophageal squamous cell carcinoma (OSCC) , including 
alcoholism, acetaldehyde exposure, smoking, and poor nutrition 
are common to both, macrocytosis has been used as a predictor of 
early OSCC in alcoholics. MCV and alcohol flushing might be used 
to better select candidates to screen this high-mortality-rate cancer 
not only in alcoholics but also in nonalcoholic men (16). 
2- Nutrition:-In high-risk areas of China, a deficiency in certain 
trace elements and the consumption of pickled or mouldy foods 
(which are potential sources of nitrosamines) have been 
suggested . Dietary folate has been inversely related to the risk of 
several cancers. Although, studies on the role of dietary folate in 
oesophageal cancer are scanty, dietary folate was inversely 
related to OSCC risk (17). 
3- Hot beverages:- Worldwide, one of the most common risk 
factors appears to be the consumption of burning-hot beverages 
which cause thermal injury leading to chronic oesophagitis and 
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then to precancerous lesions. A controversial nationwide 
population-based case-control study in Sweden about the relation 
between hot beverage consumption and oesophageal cancer 
concluded that, drinking beverages very hot did not increase the 
risk for oesophageal squamous cell carcinoma, oesophageal 
adenocarcinoma, or gastric cardia adenocarcinoma .(18). 
4- HPV:- Conflicting reports have proposed a role for infectious 
agents, including human papillomavirus (HPV) infection.   
Associations between achalasia, Plummer-Vinson syndrome, 
celiac disease and tylosis (focal noneepidermolytic palmoplantar 
keratoderma) with oesophageal cancer have also been described. 
- Localization:- 
 Oesophageal SCC is located predominantly in the middle and the 
lower third of the oesophagus, only 10-15% being situated in the 
upper third. Nearly half of the SCC occurred in the middle of the 
oesophagus (11) 
- Macroscopy:- 
 The gross appearance varies according to whether it is detected 
in an early or an advanced stage of the disease.  Among early 
SCC, polypoid, plaque-like, depressed and occult lesions have 
been described.  For the macroscopic classification of advanced 
oesophageal SCC, Ming has proposed three major patterns: 
fungating, ulcerative and infiltrating.  The fungating pattern is 
characterized by a predominantly exophytic growth, whereas in the 
ulcerative pattern, the tumor growth is predominantly intramural, 
with a central ulceration and elevated ulcer edges.  The infiltrative 
pattern, which is the least common one, also shows a 
predominantly intramural growth, but causes only a small mucosal 
defect (2).  
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- Precursor lesions:-  
The development of oesophageal SCC is thought to be a 
multistage process which progresses from the conversion of 
normal squamous epithelium to that with basal cell hyperplasia, 
intraepithelial neoplasia (dysplasia and carcinoma in situ), and 
finally, invasive SCC (2). 
Basal cell hyperplasia:- 
 This lesion is histologically defined as an otherwise normal 
squamous epithelium with a basal zone thickness greater than 
15% of total epithelial thickness, without elongation of lamina 
propria papillae.  In most cases, basal cell hyperplasia is an 
epithelial proliferative lesion in response to oesophagitis, which is 
frequently observed in high-risk populations for oesophageal 
cancer (2). 
Intraepithelial neoplasia:- 
 The lesion is about eight times more common in high cancer-
risk areas than in low-risk areas and is frequently found adjacent to 
invasive SCC in oesophagectomy specimens.  Morphological 
features of intraepithelial neoplasia include both architectural and 
cytological abnormalities.  The architectural abnormality is 
characterized by a disorganization of the epithelium and loss of 
normal cell polarity.  Cytologically, the cells exhibit irregular and 
hyperchromatic nuclei, an increase in nuclear/cytoplasmic ratio 
and increased mitotic activity.  Dysplasia is usually graded as low 
or high-grade.  In low-grade dysplasia, the abnormalities are often 
confined to the lower half of the epithelium, whereas in high-grade 
dysplasia the abnormal cells also occur in the upper half and 
exhibit a greater degree of atypia.  In carcinoma in situ, the 
atypical cells are present throughout the epithelium without 
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evidence of maturation at the surface of the epithelium.  In a two-
tier system, severe dysplasia and carcinoma-in-situ are included 
under the rubric of high-grade intraepithelial neoplasia, and may 
have the same clinical implications (2). 
 Epidemiological follow-up studies suggest an increased risk 
for the subsequent development of invasive SCC for patients with 
basal cell hyperplasia (relative risk: 2.1), low-grade dysplasia (RR: 
2.2), moderate-grade dysplasia (RR: 15.8), high-grade dysplasia 
(RR: 72.6) and carcinoma in situ (RR: 62.5).(2) 
 
-Tumor spread and staging:-    
Tumor spread:- 
 The most common sites of metastasis of oesophageal SCC 
are the regional lymph nodes.  The risk of lymph node metastasis 
is about 5% in carcinomas confined to the mucosa but over 30% in 
carcinomas invading the sub mucosa and over 80% in carcinomas 
invading adjacent organs or tissues.  Lesions of the upper third of 
the oesophagus most frequently involve cervical and mediastinal 
lymph nodes, whereas those of the middle third metastasise to the 
mediastinal, cervical and upper gastric lymph nodes.  Carcinomas 
of the lower third preferentially spread to the lower mediastinal and 
the abdominal lymph nodes.  The most common sites of 
haematogenous metastases are the lung and the liver.  Less 
frequently affected sites are the bones, adrenal glands and brain. 
(2) 
 
Superficial oesophageal carcinoma:- 
 When the tumor is confined to the mucosa or the sub 
mucosa, the term superficial oesophageal carcinoma is used 
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irrespective of the presence of regional lymph node metastases 
(2).  Intramural metastases:- 
              A special feature of oesophageal SCC is the occurrence 
of intramural metastases.  These metastases are thought to result 
from intramural lymphatic spread with the establishment of 
secondary intramural tumor deposits.  Intramural metastases are 
associated with an advanced stage of disease and with shorter 
survival (2). 
Second primary SCC:- 
 Additionally, the occurrence of multiple independent SCC 
has been described in between 14and 31% of cases, the second 
cancers being mainly carcinomas in situ and superficial SCC. 
Staging: 
 For the staging of SCC, the TNM system (tumor, node, 
metastasis) established by the international Union Against Cancer 
(UICC) is the most widely used system.  Its usefulness in the 
planning of treatment and in the prediction of prognosis has been 
validated (Appendix 2). 
Histopathology:- 
 Oesophageal SCC is defined as the penetration of neoplastic 
squamous epithelium through the epithelial basement membrane 
and extension into the lamina apropria or deeper tissue layers.  
Invasion commonly starts from a carcinoma in situ with the 
proliferation of rete-like projections of neoplastic epithelium that 
push into the lamina propria with subsequent dissociation into 
small carcinomatous cell clusters.  Along with vertical tumor cell 
infiltration, usually a horizontal growth undermines the adjacent 
normal mucosa at the tumor periphery.  The carcinoma may 
already invade intramural lymphatic vessels and veins at an early 
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stage of disease.  The frequency of lymphatic and blood vessel 
invasion increases with increasing depth of invasion.  Tumor cell in 
lymphatic vessels and in blood vessels may be found 
progressively several centimeters beyond the gross tumor.  The 
carcinoma invades the muscular layers, enters the loose fibrous 
adventitia and may extend beyond the adventitia, with invasion of 
adjacent organs or tissues, especially the trachea and bronchi, 
eventually with the formation of oesophagotracheal or 
oesophagobronchial fistulae (2).   
 Oesophageal SCC displays different microscopic patterns of 
invasion, which are categorized as ‘expansive growth’ or 
‘infiltrative growth’.  The former pattern is characterized by a broad 
and smooth invasion front with little or no tumor cell dissociation, 
whereas the infiltrative pattern shows an irregular invasion front 
and a marked tumor cell dissociation.   
 The degree of desmoplastic or inflammatory stromal 
reaction, nuclear polymorphism and keratinization is extremely 
variable.  Additionally, otherwise typical oesophageal SCC may 
contain small foci of glandular differentiation, indicated by the 
formation of tubular glands or mucin-producing tumor cells. 
Variants of squamous cell carcinoma : 
- Verrucous carcinoma:- 
 This rare variant of squamous cell carcinoma is histologically 
comparable to verrucous carcinomas arising at other sites.  On 
gross examination, its appearance is exophytic, warty, cauliflower-
like or papillary.  It can be found in any part of the oesophagus.  
Histologically, it is defined as a malignant papillary tumor 
composed of well differentiated and keratinized squamous 
epithelium with minimal cytological atypia, and pushing rather than 
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infiltrating margins. Oesophageal verrucous carcinoma grows 
slowly and invades locally, with a very low metastasizing potential 
(2). 
- Spindle cell carcinoma  
 This unusual malignancy is defined as a squamous cell 
carcinoma with a variable sarcomatoid spindle cell component.  It 
is also known by a variety of other terms, including 
carcinosarcoma, pseudosarcomatous squamous cell carcinoma, 
polypoid carcinoma and squamous cell carcinoma with a spindle 
cell component.  Macroscopically, the tumor is characterized by a 
polypoid growth pattern.  The spindle cells may be capable of 
maturation, forming bone, cartilage and skeletal muscle cells.  
Alternatively, they may be more pleomorphic, resembling 
malignant fibrous histocytoma.  In the majority of cases a gradual 
transition between carcinomatous and sarcomatous components 
has been observed on the light microscopic level.  
Immunohistochemical and electron microscopic studies indicate 
that the sarcomatous spindle cells show various degrees of 
epithelial differentiation.  Therefore, the sarcomatous component 
may be metaplastic.  However, a recent molecular analysis of a 
single case of a spindle cell carcinoma showed divergent genetic 
alterations in the carcinomatous and in the sarcomatous  tumor 
component suggesting two independent malignant cell clones (2). 
Basaloid squamous cell carcinoma:- 
 This rare but distinct variant of oesophageal SCC appears to 
be identical to the basaloid squamous cell carcinomas of the upper 
aerodigestive tract.  Histologically, it is composed of closely 
packed cells with hyperchromatic nuclei and scant basophilic 
cytoplasm, which show a solid growth pattern, small gland-like 
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spaces and foci of comedo-type necrosis.  Basaloid squamous cell 
carcinomas are associated with intraepithelial neoplasia, invasive 
SCC or islands of squamous differentiation among the basaloid 
cells.  The proliferative activity is higher than in typical SCC.  
However, basaloid squamous cell carcinoma is also characterized 
by a high rate of apoptosis and its prognosis does not differ 
significantly from that of the ordinary oesophageal SCC (2).  
 
Grading:- 
 Grading of oesophageal SCC is traditionally based on the 
parameters of mitotic activity, anisonucleosis and degree of 
differentiation (2). 
Well differentiated tumors have cytological and histological 
features similar to those of the normal oesophageal squamous 
epithelium.  In well differentiated oesophageal SCC there is a high 
proportion of large differentiated, keratinocyte-like squamous cells 
and a low proportion of small basal-type cells, which are located in 
the periphery of the cancer cell nests.  The occurrence of 
keratinization has been interpreted as a sign of differentiation, 
although the normal oesophageal squamous epithelium does not 
keratinize (2). 
Poorly differentiated tumors predominantly consist of 
basal-type cells, which usually exhibit a high mitotic rate. 
Moderately differentiated carcinomas, between the well 
and poorly differentiated types, are the most common type, 
accounting for about two-thirds of all oesophageal SCC. 
Undifferentiated carcinomas are defined by a lack of 
definite light microscopic features of differentiation.  However, 
ultrastructural or immunohistochemical investigations may disclose 
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features of squamous differentiation in a subset of light-
microscopically undifferentiated carcinomas (2). 
 Clinical features:- 
Symptoms and signs:- 
 The most common symptoms of advanced oesophageal 
cancer are dysphagia, weight loss, retrosternal or epigastric pain 
and regurgitation caused by narrowing of the oesophageal lumen 
by tumor growth.  Superficial SCC usually has no specific 
symptoms but sometimes causes a tingling sensation. 
Endoscopy and vital staining:- 
 Chromoendoscopy utilizing toluidine blue or Lugol iodine 
spray may be of value.  Toluidine blue, a metachromatic stain from 
the thiazine group, has a particular affinity for RNA and DNA and 
stains areas that are richer in nuclei than the normal mucosa.  
Lugol solution reacts specifically with glycogen in the normal 
squamous epithelium, whereas precancerous and cancerous 
lesions, but also inflamed areas and gastric heterotopia, are not 
stained.  However, the superficial extension of carcinomas 
confined to the mucosa can not be clearly recognized by simple 
endoscopy. 
Endoscopic ultrasonography:- 
 Endoscopic ultrasonography is used to evaluate both depth 
of tumor infiltration and para-oesophageal lymph node involvement 
in early and advanced stages of the disease. 
-Computed tomography (CT) and magnetic resonance imaging 
(MRI):- 
 In advanced carcinomas, CT and MRI give information on 
local and systemic spread of SCC (2). 
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Treatment groups:- 
 Following the clinical staging, patients are usually divided 
into two treatment groups: those with locoregional disease in 
whom the tumor is potentially curable (e.g. by surgery, 
radiotherapy, multimodal therapy), and those with advanced 
disease (metastases outside the regional area or invasion of the 
airway) in whom only palliative treatment is indicated.  
Oesophageal SCC limited to the mucosa may be treated by 
endoscopic mucosal resection due to its low risk of nodal 
metastasis.  Endoscopic mucosal resection is also indicated for 
high-grade intraepithelial neoplasia.  Tumors that have invaded the 
sub mucosa or those in more advanced tumor stage have more 
than 30% risk of lymph node metastasis, and endoscopic therapy 
is not indicated.  Additionally, clinical staging is performed in order 
to determine the success of treatment, e.g. following radio- and/or 
chemotherapy (2).   
 
(B) Adenocarcinoma of the oesophagus:- 
 (1) Definition and epidemiology:- 
It is malignant epithelial tumor of the oesophagus with 
glandular differentiation arising predominantly from Barrett mucosa 
in the lower third of the oesophagus.  Infrequently, adenocrcinoma 
originates from heterotopic gastric mucosa in the upper 
oesophagus, or from mucosal and submucosal glands. In the mid 
1990s the incidence of oesophageal adenocarcinoma has been 
estimated to be between 1 and 4 per 100.000 per year in the USA 
and several European countries and the incidence of oesophageal 
adenocarcinoma has risen considerably, now it is equally or even 
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more prevalent than squamous cell cancers in these regions (19), 
In Asia and Africa, adenocarcinoma of the oesophagus is an 
uncommon finding, but increasing rates are also reported from 
these areas, these include a high preponderance for the male sex 
(male: female ratio 7:1) . (20), (21), a higher incidence among 
whites and an average age at the time of diagnosis of around 65 
years. The striking male predominance in patients with 
adenocarcinoma of the oesophagus (male to female ratio of 6:1) is 
not explained by known risk factor (22).  
 
(2) Aetiology:- 
1- Barrett oesophagus: Barrett's esophagus is a premalignant 
condition and remains the number one risk factor for developing 
adenocarcinoma. Gastro-esophageal reflux disease is a strong risk 
factor for both esophageal adenocarcinoma and the precancerous 
lesion Barrett's esophagus. Both of these conditions are related to 
the reflux of acid and bile into the esophagus. This results in 
inflammation and cell damage which initiates a sequence of events 
termed the metaplasia-dysplasia sequence in which the squamous 
epithelium is replaced by columnar epithelium exhibiting increasing 
degrees of dysplasia and overt malignancy. Barrett's esophagus is 
being better recognized in patients presenting with extra-
esophageal symptoms of gastroesophageal reflux such as chronic 
cough and asthma (23 ). Barrett's esophagus is generally accepted 
as a complication of chronic and severe gastroesophageal reflux 
disease (GERD) (24). Experimental and clinical data indicate that 
combined oesophageal exposure to gastric acid and duodenal 
contents (bile acids and pancreatic enzymes) appears to be more 
detrimental than isolated exposure to gastric juice or duodenal 
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contents alone. Recent reports from some surgical series further 
suggest the importance of gastric and even duodenal reflux in the 
etiology of esophageal metaplastic development (23 ).  Combined 
reflux is thought to increase cancer risk by promoting cellular 
proliferation and by exposing the oesophageal epithelium to 
potentially genotoxic gastro and intestinal contents e.g. 
nitrosamines. However, the risk for patients with Barrett 
esophagus to develop esophageal adenocarcinoma is low, and 
most patients undergoing surveillance will not develop malignancy 
(25). Clinically Barrett's esophagus is silent in up to 90% of cases. 
Histopathologically, Barrett epithelium is characterized by two 
different types of cells, i.e. goblet cells and columnar cells and has 
also been termed ‘specialized’, ‘distinctive’ or Barrett metaplasia.  
The goblet cells stain positively with Alcian blue at low pH (2.5).  
The metaplastic epithelium has a flat or villiform surface, and is 
identical to gastric intestinal metaplasia of the incomplete type 
(type II or III).   Rarely, foci of complete intestinal metaplasia (type 
I) with absorptive cells and Paneth cells may be found.  The 
mucous glands beneath the surface epithelium and pits may also 
contain metaplastic epithelium.  Recent studies suggest that the 
columnar metaplasia originates from multipotential cells located in 
intrinsic oesophageal glands.  
Intraepithelial neoplasia in Barrett oesophagus 
 Generally has no distinctive gross features and is detected by 
systematic sampling of a flat Barrett mucosa.  The area involved is 
variable, and the presence of multiple dysplastic foci is common.In 
some cases, intraepithelial neoplasia presents as one of several 
nodular masses resembling sessile adenomas.  Here dysplastic 
lesions have been considered true adenomas, with an expanding 
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but localized growth resulting in a well demarcated interface with 
the surrounding tissue. Epithelial atypia in Barrett mucosa is 
usually assessed according to the system devised for atypia in 
ulcerative colitis, namely: negative, positive or indefinite for 
intraepithelial neoplasia.  If intraepithelial neoplasia is present, it 
should be classified as low-grade (synonymous with mild or 
moderate dysplasia) or high-grade (synonymous with severe 
dysplasia and carcinoma in situ).  The criteria used to grade 
intraepithelial neoplasia comprise cytological and architectural 
feature.  
Negative for intraepithelial neoplasia :- 
 Usually the lamina propria of Barrett mucosa contains a mild 
accompanying inflammatory infiltrate of mononuclear cells.  There 
may be mild reactive changes with enlarged, hyperchromatic 
nuclei, prominence of nucleoli, and occasional mild stratification in 
the lower portion of the glands.  However, towards the surface 
there is maturation of the epithelium with few or no abnormalities. 
Atypia indefinite for intraepithelial neoplasia 
 Is one of the major challenges for the pathologist in Barrett 
oesophagus in the differentiation of intraepithelial neoplasia from 
reactive or regenerative epithelial changes.  This is particularly 
difficult, sometimes even impossible, if erosions or ulcerations are 
present .  In areas adjacent to erosions and ulcerations, the 
metaplastic epithelium may display villiform hyperplasia of the 
surface foveolae with cytological atypia and architectural 
disturbances.  These abnormalities are usually milder than those 
observed in intraepithelial neoplasia.  There is a normal expansion 
of the basal replication zone in regenerative epithelium versus 
intraepithelial neoplasia, where the proliferation shifts to more 
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superficial portions of the gland.  If there is doubt as to whether 
reactive and regenerative changes or intraepithelial neoplasia is 
present in a biopsy, the category atypia indefinite for intraepithelial 
neoplasia is appropriate and a repeat biopsy after reflux control by 
medical acid suppression or anti-reflux therapy is indicated.  
Low-grade and high-grade intraepithelial neoplasia in Barrett 
metaplastic mucosa is defined as a neoplastic process limited to 
the epithelium.  Its prevalence in Barrett mucosa is approximately 
10% and it develops only in the intestinal type metaplastic 
epithelium. Cytological abnormalities typically extend to the 
surface of the mucosa.  In low-grade intraepithelial neoplasia, 
there is decreased mucus secretion, nuclear pseudostratification 
confined to the lower half of the glandular epithelium, occasional 
mitosis, mild pleomorphism, and minimal architectural changes. 
High-grade intraepithelial neoplasia shows marked pleomorphism 
and decrease of mucus secretion, frequent mitosis, nuclear 
stratification extending to the upper part of the cells and glands, 
and marked architectural aberrations.  The most severe 
architectural changes consist of a cribriform pattern that is a 
feature of high-grade intraepithelial neoplasia as long as the 
basement membrane of the neoplastic glands has not been 
disrupted.  The diagnostic reproducibility of intraepithelial 
neoplasia is far from perfect: significant interobserver variation 
exists (2). 
2- Tobacco:- 
 Smoking has been identified as another major risk factor for 
oesophageal adenocarcinoma and may account for as much as 
40% of cases through an early stage carcinogenic effect. Placing 
tobacco under the tongue or in the labiodental groove seems to be 
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associated with a high incidence of oral cancer and possibly also 
of oesophageal cancer ( 5 ) 
3- Obesity and diabetes mellitus:- 
 Obesity is a risk factor for adenocarcinomas of the 
oesophagus and gastric cardia. Diabetes mellitus might mediate 
that association, A study done by Rubenstein showed no 
association between diabetes mellitus and adenocarcinoma of 
oesophagus (26), (27).  
4- Alcohol:- 
 In contrast to squamous cell oesophageal carcinoma, there 
is no strong relation between alcohol consumption and 
adenocarcinoma of the oesophagus. (27). 
5- Helicobacter pylori:- 
 This infection does not appear to be a predisposing factor for 
the development of intestinal metaplasia and adenocarcinoma in 
the distal oesophagus. The relationship between H. pylori and 
GERD+ Barrett's esophagus is controversial. H. pylori eradication 
therapy may increase the risk for the development of 
gastroesophageal reflux disease GERD, which may lead to 
increase a risk factor of Barrett's esophagus and esophageal 
adenocarcinoma. Accordingly, gastric H. pylori infection may even 
exert a protective effect (24). 
- Localization:- 
 Adenocarcinoma may occur anywhere in a segment lined 
with columnar metaplastic mucosa (Barrett oesophagus) but 
develops mostly in its proximal verge.  Adenocarcinoma in a short 
segment of Barrett oesophagus is easily mistaken for 
adenocarcinoma of the cardia.   Since adenocarcinoma originating 
from the distal oesophagus may infiltrate the gastric cardia and 
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carcinoma of the gastric cardia or subcardial region may grow into 
the distal oesophagus these entities are frequently difficult to 
discriminate.  As an exception, adenocarcinoma occurs also in the 
middle or proximal third of the oesphagus, in the latter usually from 
a congenital islet of heterotopic columnar mucosa (that is present 
in up to 10% of the population) (2). 
 
 (3) Symptoms and signs Adenocarcinoma:- 
 Dysphagia is often the first symptom of advanced 
adenocarcinoma in the oesophagus.  This may be associated with 
retrosternal or epigastric pain or cachexia. Endoscopically, the 
early stages may be that of a small polypoid adenomatous-like 
lesion, but more often it is flat, depressed, elevated or occult.  
Areas with high-grade intraepithelial neoplasia are often 
multicentric and occult.  Therefore a systematic tissue sampling 
has been recommended when no abnormality is evident 
macroscopically.  The usual pattern of advanced adenocarcinoma 
at endoscopy is that of an axial, and often tight, stenosis in the 
distal third of the oesophagus: with a polypoid tumor, bleeding 
occurs at contact. Macroscopically, the majority of primary 
adenocarcinomas of the oesophagus arise in the lower third of the 
oesophagus within a segment of Barrett mucosa.  Adjacent to the 
tumor, the typical salmon-pink mucosa of Barrett oesophagus may 
be evident, especially in early carcinomas.  In the early stages, the 
gross findings of Barrett adenocarcinoma may be subtle with 
irregular mucosal bumps or small plaques.  At the time of 
diagnosis, most tumors are  advanced with deep infiltration of the 
oesophageal wall.  The advanced carcinomas are predominantly 
flat and ulcerated with only one third having a polypoid or fungating 
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appearance.  Occasionally, multifocal tumors may be present.  The 
rare adenocarcinomas arising independently of Barrett 
oesophagus from ectopic gastric glands and oesophageal glands 
display predominantly ulceration and polypoid gross features, 
respectively.  These tumors are also found in the upper and middle 
third of the oesophagus, but are rare (2). 
 
(4) Histopathology of adenocarcinoma:- 
 Adenocarcinomas arising in the setting of Barrett 
oesophagus are typically papillary and/or tubular.  A few tumors 
are of the diffuse type and show rare glandular formations, and 
sometimes signet ring cells.  Differentiation may produce 
endocrine cells, Paneth cells and squamous epithelium.  Mucinous 
adenocarcinomas i.e. tumors with more than 50% of the lesion 
consisting of mucin, also occur. About Grading; most 
adenocarcinomas arising from Barrett mucosa are well or 
moderately differentiated, and display well formed tubular or 
papillary structures.  The well differentiated tumors may pose a 
diagnostic problem in biopsy specimens because the infiltrating 
component may be difficult to recognize as invasive since Barrett 
mucosa often has irregular dispersed glands.  Glandular structures 
are only slightly formed in poorly differentiated adenocarcinomas 
and absent in undifferentiated tumors. Adenocarcinomas spread 
first locally and infiltrate the oesophageal wall.   Distal spread to 
the stomach may occur.   Extension through the oesophageal wall 
into adventitial tissue, and then into adjacent organs or tissues is 
similar to squamous cell carcinoma.  Common sites or local spread 
comprise the mediastinum, tracheobronchial tree, lung, aorta, 
pericardium, heart and spine.  Barrett associated adenocarcinoma 
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metastasizes to para-oesophageal and paracardial lymph nodes, 
those of the lesser curvature of the stomach and the celiac nodes.  
Distant metastases occur late. For staging, the TNM classification 
used for SCC is applicable to Barrett adenocarcinoma and 
provides prognostically significant data (2). 
 
 
(5) Other carcinomas:- 
- Adenosquamous carcinoma:- 
 This carcinoma has a significant squamous carcinomatous 
component that is intermingled with a tubular adenocarcinoma. 
- Mucoepidermoid carcinoma:- 
 This rare carcinoma shows an intimate mixture of squamous 
cells, mucus secreting cells and cells of an intermediate type. 
- Adenoid cystic carcinoma:- 
 This neoplasm is also infrequent and believed to arise, like 
the mucoepidermoid variant, from oesophageal glands.  Both 
lesions tend to be of salivary gland type, and small tumors may be 
confined to the submucosa. 
(6) Prognostic factors in adenocarcinoma :- 
 The major prognostic factors in adenocarcinoma of the 
oesophagus are the depth of mural invasion and the presence or 
absence of lymph node or distant metastasis.  Gross features and 
histological differentiation do not influence prognosis.  The overall 
5-year survival rate after surgery is less than 20%  in most series 
including a majority of advanced carcinomas.  The survival rates 
are better in superficial  adenocarcinoma ranging from 65% to 80% 
in different series. 
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 Since the stage at the time of diagnosis is the most important 
factor affecting outcome, endoscopic surveillance of Barrett 
patients with early detection of their adenocarcinomas, results in 
better prognosis in most cases (2). 
 
(C) Endocrine tumors of the oesophagus:- 
 Endocrine tumors of the oesophagus are rare and include 
carcinoid (well differentiated endocrine neoplasm), small cell 
carcinoma (poorly differentiated endocrine carcinoma) and mixed 
endocrine-exocrine carcinoma. Aetiologically, patients with small 
cell carcinomas often have a history of heavy smoking and one 
reported case was associated with long standing achalasia.  A 
case of combined adenocarcinoma and carcinoid occurred in a 
patient with a Barrett oesophagus.  Small cell carcinoma has also 
been associated with Barrett oesophagus. Carcinoid tumors are 
typically located in the lower third of the oesophagus.  Almost all 
small cell carcinomas occur in the distal half of the oesophagus. 
Clinically, dysphagia, severe weight loss and sometimes chest 
pain are the main symptoms of endocrine tumors of the 
oesophagus.  Patients with small cell carcinomas often present at 
an advanced stage. Inappropriate antidiuretic hormone syndrome 
and hypercalcaemia have been reported.  In addition, a case of 
watery diarrhea, hypokalaemia, achlorohydria (WDHA) syndrome 
due to ectopic production of VIP by a mixed-cell (squamous-small 
cell) carcinoma of the oesophagus has been described. 
Macroscopically, all reported oesophageal carcinoids were of 
large size (from 4 to 7 cm in diameter) and infiltrated deeply the 
oesophageal wall.  Small cell carcinomas usually appear as 
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fungating or ulcerated masses of large size, measuring from 4 to14 
cm in greatest diameter (2).  
Histopathologically, all carcinoids so far reported in the 
literature have been described as deeply infiltrative tumors, with 
high mitotic rate and metastases.  Microscopically they are 
composed of solid nests of tumor cells that show positive stain for 
Grimelius and neuron-specific enolase, and characteristic 
membrane-bound neurosecretory granules at ultrastructural 
examination. Small cell carcinoma of the oesophagus is 
indistinguishable from its counterpart in the lung according to 
histological and immunohistochemical features as well as clinical 
behaviour.  The cells may be small with dark nuclei of round or 
oval shape and scanty cytoplasm, or be larger with more 
cytoplasm (intermediate cells) forming solid sheets and nests.  
There may be foci of squamous carcinoma, adenocarcinoma, 
and/or mucoepidermoid carcinoma, a finding that raises the 
possibility of an origin of tumor cells from pluripotent cells present 
in the squamous epithelium or ducts of the submucosal glands.  
Argyrophylic granules can be demonstrated by Grimelius stain and 
small dense-core granules are always detected by electron 
microscopy. Mixed endocrine-exocrine carcinoma, a rare tumor 
with few reported cases. There is combination of  gastrointestinal 
type adenocarcinoma with the trabecular-acinar component of a 
carcinoid (2).   
 
Prognostic factors:-Two of three oesophageal carcinoids from 
the analysis of 8305 cases of carcinoid tumors were associated 
with distant metastases and one  of the three reported cases  died 
29 months after surgery.  The prognosis of small cell carcinoma of 
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the oesophagus is poor, even when the primary growth is limited.  
The survival period is usually less than 6 months.  Multidrug 
chemotherapy may offer temporary remission (2). 
 
 (D) Lymphoma of the oesophagus:- 
Definition:- Primary lymphoma of the oesophagus is defined as 
an extranodal lymphoma arising in the oesophagus with the bulk of 
the disease localized to this site.  Contiguous lymph node 
involvement and distant spread may be seen but the primary 
clinical presentation is in the oesophagus with therapy directed at 
this site. 
Clinical features:- The oesophagus is the least common site of 
involvement with lymphoma in the digestive tract, accounting for 
less than 1% of lymphoma patients.  Oesophageal involvement is 
usually secondary either from the mediastinum, from nodal 
disease or from a primary gastric location.  Patients are frequently 
male and usually over 50 years old.  Tumors involving the distal 
portion of the oesophagus may cause dysphagia. 
Histopathology:-Primary oesophageal lymphomas may be of 
large B-cell type or may be low-grade B-cell MALT lymphomas.  
MALT lymphomas show morphological and cytological features 
common to MALT lymphomas found elsewhere in the digestive 
tract.  Lymphoid follicles are surrounded by a diffuse infiltrate of 
centrocyte-like (CCL) cells showing a variable degree of plasma 
cell differentiation.  Infiltration of these cells into the overlying 
epithelium is usually seen.  In common with other sites in the 
digestive tract, secondary involvement of the oesophagus may 
occur in dissemination of any type of lymphoma. Primary 
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oesophageal T-cell lymphoma has been described but is 
exceedingly rare (2). 
 
 
 (E) Mesenchymal tumors of the oesophagus:- 
Definition:-A variety of rare benign and malignant mesenchymal 
tumors that arise in the oesophagus.  Among these, tumors of 
smooth muscle or ‘stromal’ type are most common. 
Epidemiology:-  
Sarcomas of the oesophagus accounted for 0.2% of malignant 
oesophageal tumors in the United States from 1973 to 1987.  
Males were more frequently affected than females by nearly 2:1.  
Adults between the 6th and 8th decades are primarily affected.  
Leiomyoma is the most common benign  mesenchymal tumor of 
the oesophagus. and constitute 0.4 - 1.5% of all tumours of this 
organ (28 ), Although leiomyomas are the most common benign 
tumors of the esophagus, esophageal leiomyomatosis is a rare 
pathological entity, and pedunculated presentation is even 
rarer(29). Esophageal leiomyoma usually originates from the 
muscle layer of the esophageal wall and grows spirally around the 
esophageal axis. (30). It occurs in males at twice the frequency as 
females and has a median age distribution between 30 and 35 
years, are most frequent in the lower oesophagus and begin as 
intramural lesions.  The larger tumors can extend to mediastinum 
and form a predominantly mediastinal mass. Leiomyomas are 
usually very slow growing and often asymptomatic. Symptomatic 
tumors are usually greater than five centimeters in diameter (31). 
Diffuse leiomyomatosis of the oesophagus is a rare entity among 
oesophageal diseases. Histopathologically it is characterized by 
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diffuse hypertrophy of the muscular layer extending to the whole 
oesophagus predominantly in the lower third, where it can result in 
tumour formation. Leiomyomatosis can involve the upper part of 
the stomach and is frequently associated with genital or 
tracheobronchial (bronchitracheal) muscular localizations. Also, it 
can be associated with Alport's syndrome in familial cases (32 ). 
Leiomyomatosis forms worm-like intramural structures that may 
extend into the upper portion of the stomach. Clinically, dysphagia 
is the usual complaint, but many leiomyomas and a small 
proportion of stromal tumors are asymptomatic and are incidentally 
detected by x-ray as mediastinal masses.  Since most sarcomas 
project into the lumen, they are relatively easy to diagnose by 
endoscopy or imaging studies.  The endoscopic pattern is that of a 
submucosal tumor with a swelling of a normal mucosa.  
Endoscopic ultrasound helps in determining the actual size of the 
tumor, its position in the oesophageal wall and its eventual position 
in the mediastinum. Esophageal leiomyomatosis should be 
considered in a young patient with long-standing dysphagia in 
whom smooth, tapered esophageal narrowing on barium study and 
circumferential esophageal wall thickening on CT scan are seen. 
(33). Macroscopically Leiomyomas vary in size from a few 
millimeters up to 10 cm in diameter (average 2-3 cm).  They can 
form sausage-like masses with a large longitudinal dimension or 
dumb-bell shaped masses with circular involvement.  Large 
leiomyomas (over 0.5 kg) have been described.  Sarcomas, most 
of them representing malignant gastrointestinal stromal tumors 
(GISTs), are typically multinodular or less commonly plaque-like 
masses resembling sarcomas of the soft tissues.  Many 
oesophageal sarcomas protrude into the mediastinum. 
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Histopathologically, Leiomyoma is composed of bland spindle 
cells and shows low or moderate cellularity and slight if any mitotic 
activity.  There may be focal nuclear atypia.  The cells have 
eosinophilic, fibrillary, often clumped cytoplasm.  Eosinophilic 
granulocytes and spherical calcifications are sometimes present.  
Leiomyomas are typically globally positive for desmin and smooth, 
muscle actin and are negative for CD34 and CD 117(KIT). 
Leiomyomas should be removed when diagnosed, even if 
asymptomatic, because malignancy cannot otherwise be excluded 
and symptoms are likely to develop if treatment is delayed or 
omitted (34). 
Leiomyosarcoma, a malignant tumor featuring differentiated 
smooth muscle cells is rare in the oesophagus.  In a recent series, 
such tumors comprised 4% of all combined smooth muscle and 
stromal tumors.  They were large tumors that presented in older 
adults, and all patients died of disease.  Diagnosis is based on 
demonstration of smooth muscle differentiation by a-smooth 
muscle actin, desmin or both, and lack of KIT expression. 
          Stromal tumors (GISTs) are rare in the oesophagus, and 
comprise 20-30% of the combined cases of smooth muscle and 
stromal tumors.  Like elsewhere in the digestive system, they 
predominantly occur in older adults between the 6th and 8th 
decades, oesophageal stromal tumors may have a male 
predominance.  Most oesophageal examples are spindle cell 
tumors, and a minority is epithelioid.  Oesophageal GISTs are 
identical with their gastric counterparts by their positivity for KIT 
and CD 34, variable reactivity for smooth muscle actin and general 
negativity for desmin.  Most are clinically malignant, and commonly 
develop liver metastases.  The oesophageal tumors analyzed to 
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date have shown similar c-kit mutations (exon 11) as observed in 
gastric and intestinal GISTs.  
Prognosis:- The prognosis of oesophageal sarcomas, like 
carcinomas, is largely dependent on the size, depth of invasion 
and presence or absence of metastasis. 
 
(F) Melanoma of the oesophagus:- 
 Malignant melanoma in the oesophagus is much more 
commonly metastatic than primary. Primary malignant melanoma 
of the esophagus is rare, and its symptoms are similar to those of 
squamous cell carcinoma (35), (36). Primary oesophageal 
melanomas are usually polypoid and are clinically aggressive 
lesions.  They are believed to arise from a zone of atypical 
junctional proliferation of melanocytes and such a proliferation is 
often present adjacent to the invasive tumor, although it may not 
be observed in advanced disease. The histology of the invasive 
component is indistinguishable from cutaneous melanoma.  
Growth is typically expansile rather than infiltrative.. In a case 
report, melanoma was misdiagnosed in biopsy taken during 
endoscopy. Final precise establishing the character of the lesion 
was able during histopathological examination of the specimen 
obtained during surgery. The outcome of the treatment was poor--
survival time did not exceed 14 months. Patient died because of 
pulmonary metastases. (37). The clinical presentation of this 
uncommon tumour is similar to esophageal carcinoma and the 
preoperative diagnosis may be difficult and total esophagectomy is 
the treatment of choice (38). 
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(G) Secondary tumors of the oesophagus:- 
Definition:- Tumors of the oesophagus that originate from but are 
discontinuous with a primary tumor elsewhere in the oesophagus 
or an extra-oesophageal neoplasm. 
Incidence:- Metastatic spread to the oesophagus is uncommon.  
An unusually high frequency (6.1% of autopsy cases) was reported 
from Japan. 
Origin of metastases:- Neoplasms of neighbouring organs such 
as pharynx or gastric cardia can spread to the oesophagus via 
lymphatics.  Haematogenous metastases from any primary 
localization may occur.  Reported primary sites include thyroid, 
lung, breast, skin, kidney, prostate and ovary.   
Localization:- The most common site of involvement is the middle 
third of the oesophagus. 
Clinical features:- The leading symptom is dysphagia whereas 
achalasia and upper gastrointestinal bleeding with anaemia are 
unusual . Barium swallow examination, endoscopy, computed 
tomography and magnetic resonance imaging demonstrate in most 
cases a submucosal tumor, but any aspect resembling a primary 
oesophageal carcinoma may be observed. 
Histopathological and predictive factors:- Submucosal 
localizaiotn without invasion of the mucosa is characteristic for a 
metastasis.  Early metastases of gastric and oesphageal tumors 
into the oesophagus may be local indicators of systemic spread.  
The presence of metastasis in the oesphagus is a sign of poor 
prognosis, but the outcome is much better when the primary tumor 
growth rate is slow and when other metastases are excluded. 
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General objective: 
           -To study oesophageal tumours in Sudanese patients. 
 Specific Objective:  
1- To identify the different histopathological patterns of 
oesophageal tumours in Sudanese patients. 
2- To know the sex distribution among Sudanese patients 
with oesophageal tumours. 
3- To determine the age distribution among Sudanese 
patients with oesophageal tumours. 
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Materials and method 
* The study design :  
     This is a descriptive retrospective study done in Ibn Sina 
Hospital and the National Health Laboratory ( N.H.L) in 
Khartoum, Sudan. Ibn Sina Hospital is a specialized  hospital in 
renal and gastrointestinal diseases. It receives patients from 
different regions of Sudan for diagnosis  and management. The 
National Health Laboratory is a national reference laboratory in 
Khartoum, Sudan. 
* The study population : 
      The study include all patients with oesophageal tumours 
presented to Ibn Sina hospital and the National Health 
Laboratory between January 2000 through to  December 2004. 
* Inclusion criteria :  
    All patients with oesophageal tumours who underwent 
endoscopic or histopathologic studies for diagnosis. 
* Exclusion criteria :  
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       Patients who had no histopathological slides in the 
histopathology laboratory of Ibn Sina hospital and the National 
Health Laboratory. 
* Tools of data collection:  
    Data is collected in a predesigned questionnaire with detailed 
history and investigation. The slides of  histopathological 
diagnosis for all patients were collected and revised to confirm 
the diagnosis and to determine the histopathological type using 
the WHO classification of oesophageal tumours ( appendix 1) 
and grades the tumour using the well differentiated, moderately 
differentiated and poorly differentiated grading system.    
     The data is electronically  analysed using the computer 
program SPSS. A P-value of < 0.05 is considered significant.  
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Results 
 
 
           About 102 cases of oesophageal biopsies were studied. All were 
malignant. The age and sex distribution, presenting symptoms, sites, 
histopathological pattern, and the behaviour of the tumour were recorded 
and the following results obtained:  
 
(1) Age Distribution:  
       The ages range from 29 years to 90 with the mean age 65 years. 60% 
of patients are above 60 years, 39% between 30 and 60 years, and 1 % 
below 30 years. ( Figure 1).  
 
(2) Sex distribution: 
       Forty five patients (44%) were males and 56% were females with a 
ratio of female to male of 1.3: 1, (Figure 2). In squamous cell carcinoma 
34 patients (38%) were males and 56 patients (62%) were females, with a 
female to male ratio of 1.6:1. In adenocarcinoma ten patients were males 
(91%) and only one patient was a female (9%), with a male to female 
ratio of 10:1. (Table 1). 
 
(3) Clinical symptoms: 
           93 patients (91%) presented with dysphagia, 6 patients (6%) 
presented with dysphagia and weight loss and one patient (1%) presented 
with dysphagia and retrosternal pain. Two patients (2%) presented with 
weight loss only. ( Table 2). 
 
(4) Site distribution of the tumours: 
         For squamous cell carcinoma 34 patients (38%) had the tumour in 
the distal third of the oesophagus, 45 patients (50%) in the middle third 
and 11 patients (12%) in the upper third. (Figure 3). For adenocarcinoma: 
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10 patients (90%) in the lower third and one patient (10%) in the middle 
third. No one was found in the upper third. (Table 3). 
 
(5) Histopathological pattern: 
        For squamous cell and its variants: 84 cases (82%) of all the 
oesophageal tumours  were squamous cell carcinoma, 4 cases (4%) 
basaloid squamous cell carcinoma, 2 cases (2%) spindle cell carcinoma. 
For adenocarcinoma and its variants: 9 cases (9%) of all the oesophageal 
tumours were adenocarcinoma, one case (1%) papillary carcinoma, and 
one case (1%) signet ring cell carcinoma. ( Table 4). 
 
(6) Grading: 
             For squamous cell carcinoma: moderately differentiated 43 cases 
(48%), poorly differentiated 30 cases (33 %), and well differentiated 17 
cases (19 %) . (Table 5).  For adenocarcinoma moderately differentiated 7 
cases (64%), poorly differentiated one case (9%), well differentiated 3 
cases (27 %). (Table 6). 
   
(7) Invasion of squamous cell carcinoma  
         80 cases (88%) were invasive, and 11 cases (12%) were 
intraepithelial neoplasia. (Figure 4). 
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Figure (1) Age distibutionin oesophageal tumours in years
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Figure (2) Sex distribution in oesophageal tumours
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Type Male Female Total Percent 
Squamous cell  34 (38%) 56 (62%) 90 88 % 
Adenocarcinoma 10 (91%) 1 (9%) 11 11 % 
Undifferentiated - 1 1 1 % 
Total 44 (43%) 58 (57%) 102 100 % 
 
Table (1) Types of esophageal cancer 
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Symptom Number of patients. Percent 
Dysphagia 93 91 % 
Dysphagia + wt loss 6 6 % 
Dysphagia + retrosternal pain 1 1 % 
Wt loss only 2 2 % 
Total 102 100 % 
 
Table (2) Presenting symptoms 
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Site No. Percent 
Middle third 1 10 % 
Lower third 10 90 % 
Total 11 100 % 
 
Table (3) Site of the tumour 
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Type No. Percent 
*Squamous cell carcinoma 84 82 % 
-Basoloid Squamous cell carcinoma 4 4 % 
-Spindle cell carcinomqa 2 2 % 
*Adenocarcinoma 9 9 % 
-Papillary Adenocarcinoma 1 1 % 
-Signet ring cell carcinoma 1 1 % 
* Undifferentiated  1 1% 
Total 102 100 % 
 
Table (4) Histolopathological pattern of esophageal tumors : 
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Differentiation No. Percent 
Well differentiated 17 19 % 
Moderately differentiated 43 48 % 
Poorly differentiated 30 33 % 
Total 90 100 % 
 
Table (5) Grading of squamous cell carcinoma 
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Differentiation No. Percent 
Well differentiated 3 27 % 
Moderately differentiated 7 64 % 
Poorly differentiated 1 9 % 
Total 11 100 % 
 
Table (6) Grading of adenocarcinoma 
 
 
 
:  
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Discussion 
 
           This is a descriptive retrospective study about oesophageal 
tumours in Sudanese patients. It includes 102 cases. All were found to be 
malignant tumours, the histology of which is squamous cell carcinoma 
and adenocarcinoma. This is consistent with the fact that benign tumours 
like leiomioma and other malignant tumours like endocrine tumours and 
lymphomas are rare as mentioned in the literature.  
         In Sudan as in many developing countries, there is at present no 
reliable statistical information on absolute cancer rate. In this study, the 
result is in accordance with the world wide acceptance that SCC is the 
most common oesophageal cancer representing 89.1%.  
  
Sex distribution: 
        The male to female ratio for SCC in Sudanese patients did not 
change over the last 20 years. In this study it is found to be 1:1.26 
compared to an older study done in 1987 which showed a ratio of 1:1.25 
(39). In Pakistan the ratio is 1:1.2 almost the same. However, studies in 
Thailand and USA showed male predominance, 3.45:1 and 3:1 
respectively. This puzzling epidemiologic contrast is not explained. 
        For adenocarcinoma there is striking male predominance, 10:1 
which is a similar finding in many studies in different countries. It was 
hypothesized that sex hormones could be responsible for that sex 
imbalance. However, a Swedish study concluded that there is no role of 
sex hormones in the aetiology of oesophageal adenocarcinoma. Another 
study done in the USA showed that the ratio is 7:1 in whites and 10:1 in 
blacks (11). This may suggest a genetic implication and this merit further 
investigation.       
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Age distribution:  
         The ages of the patients range from 29-90 years, with a 
mean of 65 years. The commoner age group was 60-90 years for 
both SCC and adenocarcinoma, which is the same age group in 
Almasri SH study in the period 1965-1974 in Sudan (5). One case 
was found to be basaloid squamous cell carcinoma and it was 
found in young age group (29 years). This result goes with the 
international age distribution of oesophageal malignancy. 
 
Presenting symptoms:  
         Dysphagia was the most frequent symptom and 
unfortunately a late warning one. Other symptom noticed was 
weight loss. These symptoms were the same worldwide and are 
the most bothering signs that lead the patient to seek medical 
advice.    
 
Site of the tumour: 
         Fifty percent of SCC occurred in the middle third and 38% in 
the lower third in accordance with many studies done in the USA, 
Nigeria and other countries. The majority of adenocarcinoma 
arouse in the lower third because most of which arise in Barret 
oesophagus.  
  
Histological pattern: 
      In this study, the SCC variants basaloid cell carcinoma and 
spindle cell carcinoma were commoner in females while 
adenocarcinoma with its different histological patterns, namely 
papillary adenocarcinoma and signet ring carcinoma were found in 
males. One case was undifferentiated carcinoma and was a 
female. The majority of squamous cell and adenocarcinomas were 
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moderately differentiated. However the prognostic impact of 
tumour differentiation is equivocal possibly due poor 
standardization of the grading system and to the high prognostic 
power of tumour stage (WHO). Invasive squamous cell carcinomas 
represent the majority of cases (88%) while the rest were 
intraepithelial neoplasia. This implies that, the diagnosis of 
oesophageal cancer is usually late and necessitates the need for 
mass screening particularly for high risk patients. 
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Conclusion 
 
1- Benign Oesophageal tumours and some malignant tumours 
like endocrine tumours and lymphomas are rare in Sudan. 
2- The most common type of oesophageal cancer in Sudan is 
squamous cell carcinoma 
3- There is striking male predominance in Sudanese patients 
with adenocarcinoma. 
4- The male to female ratio in Sudanese patient with squamous 
cell carcinoma remained static over the last twenty years. 
5- The common age group for oesophageal cancer in 
Sudanese patients is 60-90 years. 
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Recommendation 
 
It is recommended that: 
(1) Establishment of screening programs for oesophageal carcinoma 
for the high risk group. 
(2) Further studies should be carried out to clarify exact risk factors. 
(3) Detailed histopathological diagnosis and staging is needed. 
(4) Provision of histopathology facilities for all regional hospitals. 
(5)  The statistical and registry services should be improved at both 
national and regional levels. 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 60
Appendix  
 
 Appendix (1) WHO histological classification of esophageal tumors 
Epithelial tumors 
Squamous cell papilloma 
Intraepithelial neoplasia 
   Squamous 
  Glandular (adenoma) 
Carcinoma 
  Squamous cell carcinoma 
  Verrucous (squamous) carcinoma 
  Basaloid squamous cell carcinoma 
  Spindle cell (squamous) carcinoma 
  Adenocarcinoma 
  Adenosquamous carcinoma 
  Mucoepidermoid carcinoma 
  Adenoid cystic carcinoma 
  Small cell carcinoma 
  Undifferentiated carcinoma 
  Others 
Carcinoid tumor 
Non-epithelial tumors 
Leiomyoma 
Lipoma 
Granular cell tumor 
Gastrointestinal stromal tumor 
    Benign 
    Uncertain malignant potential 
    Malignant 
Leiomyosarcoma 
Rhabdomyosarcoma 
Kaposi sarcoma 
Malignant melanoma 
Others 
Secondary tumors 
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Appendix (2): TNM classification of oesophageal tumors ِ 
 
T-     Primary tumor 
TX Primary tumor cannot be assessed 
TO No evidence of primary tumor 
Tis Carcinoma in situ 
T1  Tumor invades lamina propria or sub mucosa 
T2  Tumor invades muscularis propria 
T3  Tumor invades adventitia 
T4  Tumor invades adjacent structures 
N- Regional lymph nodes 
N+ Regional lymph nodes cannot be assessed 
NO No regional lymph node metastasis 
N1 Regional lymph node metastasis 
M- Distant metastasis 
M+ Distant metastasis cannot be assessed 
MO No distant metastasis 
M1 Distant metastasis 
For tumors of lower thoracic  oesophagus 
M1a Metastasis in celiac lymph nodes 
M1b other distant metastasis  
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Appendix (3) Data sheet 
 
 
1- Name                    2- Lab No  
3- Residence     4- Age   
5- Sex   Male [       ] Female [       ]  
6- Tribe 
7- Clinical remarks: 
   a- Not written  [       ]    
b- Dysphagia   [       ]     
c- Wt loss    [       ]          
d- Others   [       ]         
8-Biopsy report: 
a- Site of the tumor 
b- Gross appearance 
c- Others 
d- No report 
    8-Histopathology report:  
a- Squamous cell carcinoma: 
1- Differentiation  
Well [     ]  Moderate [     ]     Poor [      ]  
  2- Variants  
- Spindle cell  [       ] 
   - Pseudosarcoma  [       ] 
   -Verrucous carcinoma [       ] 
  3- Carcinoma in situ  [       ] 
  4- Dysplasia    [       ] 
 b- Adenocarcinoma differentiation 
   Well [     ]  Moderate [     ]    Poor [      ] 
c- Other tumours 
 
d- Notes and comments   
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Appendix (4) Slides: 
 
 
 
 
 
Slide (1) :Undifferentiated carcinoma. No glandular or squamous 
structure (H&E  X40)  
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Sٍlide (2) Well differentiated squamous cell carcinoma, showing two 
squamous cell nests with keratin (H&E  X20).  
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Slide (3) : Squamous intraepithelial neoplasia type III 
  (squamous cell carcinoma in situ) (H&E X20) 
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Slide (4): Moderate differentiated squamous cell carcinoma 
infiltrating muscle fibres (H&E X20) 
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Slide (5): Basaloid squamous cell carcinoma (H&E  X 10) 
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Slide (6): Signet ring carcinoma. Consisting of signet ring cells 
containing intracellular mucin (H&E X20) 
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Slide (7): Spindle cell carcinoma (H&E X20) 
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Slide (8): Papillary adenocarcinomas (H&E X10) 
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Slide (9): Moderately differentiated squamous cell carcinoma 
 (H&E X20) 
 
 
 
 
 
 
 
 72
 
 
 
 
 
 
 
 
 
Slide (10): Poorly differentiated adenocarcinoma 
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